Literature DB >> 19533055

[Microscopic polyangiitis as etiology for lung fibrosis--a known but often late-diagnosed cause].

Daniela Rosa Gompelmann1, Heinrich Wenz, Claus Peter Heussel, Felix J Herth.   

Abstract

BACKGROUND AND
PURPOSE: Lung fibrosis as first symptomatic manifestation of microscopic polyangiitis (MPA) is rare. It is characterized by progressive exertional dyspnea, radiologic detection of reticular shadowing, and increased titers of MPA-associated autoantibodies. This case study shall remind of the rare treatable cause of lung fibrosis. CASE REPORT: A 78-year-old male patient with long-standing exertional dyspnea and typical chest radiograph appearances of advanced lung fibrosis is presented. The finding of MPA autoantibodies in laboratory tests was decisive to confirm the diagnosis of MPA, and a therapy adapted to the disease severity could be initiated.
CONCLUSION: An early diagnosis of MPA and a fast onset of therapy are important, because the influence of an already existent lung fibrosis is uncertain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533055     DOI: 10.1007/s00063-009-1097-4

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  7 in total

Review 1.  Microscopic polyangiitis (microscopic polyarteritis).

Authors:  J C Jennette; D B Thomas; R J Falk
Journal:  Semin Diagn Pathol       Date:  2001-02       Impact factor: 3.464

Review 2.  [Pulmonary vasculitis. Lung support in systemic vascular deterioration].

Authors:  A Schnabel; W L Gross
Journal:  Pneumologie       Date:  2000-06

Review 3.  [Primary systemic vasculitides. Part III. Pathogenesis and therapy].

Authors:  W L Gross
Journal:  Internist (Berl)       Date:  1999-11       Impact factor: 0.743

4.  EULAR recommendations for the management of primary small and medium vessel vasculitis.

Authors:  C Mukhtyar; L Guillevin; M C Cid; B Dasgupta; K de Groot; W Gross; T Hauser; B Hellmich; D Jayne; C G M Kallenberg; P A Merkel; H Raspe; C Salvarani; D G I Scott; C Stegeman; R Watts; K Westman; J Witter; H Yazici; R Luqmani
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

5.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

6.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

Review 7.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

  7 in total
  1 in total

1.  Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?

Authors:  Amir Bhanji; Mahzuz Karim
Journal:  NDT Plus       Date:  2010-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.